healthcare

New Business

Ant Group picks AI-assisted healthcare as new growth area amid China’s rapid ageing

Chinese fintech firm Ant Group, an affiliate of Alibaba Group Holding, has picked healthcare as a new artificial intelligence-driven business…

Read More »
New Business

China must stay focused on ‘own work’ despite external challenges, Xi says

During the preparatory period for China’s next five-year plan, President Xi Jinping stressed the country needed to stick to its…

Read More »
New Business

Chinese healthcare, biotech firms flock to Hong Kong for IPOs

Eleven Chinese healthcare and biotechnology companies filed applications to list on the Hong Kong stock exchange in the last two…

Read More »
New Business

Forum on healthcare addresses unethical practices in Pakistan

Pakistan’s healthcare regulators, medical bodies and pharmaceutical representatives came together on Monday to address rampant unethical practices in the country’s…

Read More »
New Business

Adrian Cheng sharpens focus on ‘transformative industries’ under new firm ALMAD Group

Adrian Cheng Chi-kong has launched a new business focused on “transformative industries”, including culture and healthcare, nearly three months after…

Read More »
New Business

Working in Hong Kong, living in Shenzhen: why people are making move to mainland city

At 8.30am on Monday, 24-year-old Lisa Sun leaves her flat in Shenzhen and begins her long commute to work. It…

Read More »
New Business

China pledges more consumption incentives to service the service sector

China has vowed to continue cutting red tape and attracting foreign investment to boost service consumption over the next five…

Read More »
New Business

Opinion | Will China’s bid to boost domestic demand pay off?

At the World Economic Forum’s “Summer Davos” meeting in Tianjin last month, Premier Li Qiang said that China is evolving…

Read More »
New Business

Biotech’s DeepSeek moment: Hong Kong investor ORI sees opportunity in China with new fund

Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as…

Read More »
New Business

Ahead of Hong Kong IPO, China drug maker Hengrui touts partnership with US giant Merck

Jiangsu Hengrui Pharmaceuticals, a leading Chinese developer of novel drugs that recently received approval to go public in Hong Kong,…

Read More »
Back to top button